Coexistence of in vivo modified low-density lipoprotein (LDL) and placental binding sites for acetyl-LDL: A complementary source of cholesterol for the human placenta

Placenta ◽  
1986 ◽  
Vol 7 (5) ◽  
pp. 488
Author(s):  
E. Alsat ◽  
F. Mondon ◽  
R. Rebourcet ◽  
M. Berthelier ◽  
S. Goldstein ◽  
...  
1984 ◽  
Vol 38 (2-3) ◽  
pp. 197-203 ◽  
Author(s):  
Eliane Alsat ◽  
Yamina Bouali ◽  
Sonia Goldstein ◽  
André Malassiné ◽  
Martine Berthelier ◽  
...  

1985 ◽  
Vol 41 (2-3) ◽  
pp. 229-235 ◽  
Author(s):  
Eliane Alsat ◽  
Françoise Mondon ◽  
Régis Rebourcet ◽  
Martine Berthelier ◽  
Daniele Erlich ◽  
...  

1985 ◽  
Vol 4 (5) ◽  
pp. 1157-1162 ◽  
Author(s):  
H.A. Dresel ◽  
E. Friedrich ◽  
D.P. Via ◽  
G. Schettler ◽  
H. Sinn

Circulation ◽  
1996 ◽  
Vol 94 (7) ◽  
pp. 1698-1704 ◽  
Author(s):  
Klaus Juul ◽  
Lars B. Nielsen ◽  
Klaus Munkholm ◽  
Steen Stender ◽  
Børge G. Nordestgaard

1986 ◽  
Vol 234 (1) ◽  
pp. 245-248 ◽  
Author(s):  
W Jessup ◽  
G Jurgens ◽  
J Lang ◽  
H Esterbauer ◽  
R T Dean

The incorporation of the lipid peroxidation product 4-hydroxynonenal into low-density lipoprotein (LDL) increases the negative charge of the particle, and decreases its affinity for the fibroblast LDL receptor. It is suggested that this modification may occur in vivo, and might promote atherogenesis.


1994 ◽  
Vol 35 (4) ◽  
pp. 669-677
Author(s):  
H.N. Hodis ◽  
D.M. Kramsch ◽  
P. Avogaro ◽  
G. Bittolo-Bon ◽  
G. Cazzolato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document